Gene: SLC25A24
Official Full Name: solute carrier family 25 member 24provided by HGNC
Gene Summary: This gene encodes a carrier protein that transports ATP-Mg exchanging it for phosphate. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26901 | SLC25A24 Knockout cell line (HeLa) | Human | SLC25A24 | 1:3~1:6 | Negative | Online Inquiry |
KO26902 | SLC25A24 Knockout cell line (HCT 116) | Human | SLC25A24 | 1:2~1:4 | Negative | Online Inquiry |
KO26903 | SLC25A24 Knockout cell line (HEK293) | Human | SLC25A24 | 1:3~1:6 | Negative | Online Inquiry |
KO26904 | SLC25A24 Knockout cell line (A549) | Human | SLC25A24 | 1:3~1:4 | Negative | Online Inquiry |
SLC25A24 Gene Knockout Cell Lines are genetically engineered models specifically designed to investigate the role of the SLC25A24 gene, which encodes a mitochondrial carrier protein involved in amino acid metabolism and energy homeostasis. These knockout cell lines provide a platform for elucidating the gene's functional contributions at the cellular level, particularly in conditions related to metabolic disorders, mitochondrial dysfunctions, and various diseases.
The primary function of SLC25A24-related knockout cell lines lies in their ability to facilitate studies on gene function, protein interaction, and metabolic pathways. By disrupting the SLC25A24 gene, researchers can observe altered phenotypic responses, metabolic changes, and variations in cellular signaling pathways. This is crucial for understanding the molecular mechanisms underlying conditions such as obesity, diabetes, and neurodegenerative diseases, thereby advancing the field of metabolic research.
In scientific and clinical research settings, these knockout cell lines serve as invaluable tools for drug discovery and therapeutic development. They enable researchers to screen compounds, identify potential drug targets, and evaluate the effects of treatments on cellular metabolism and mitochondrial dynamics. Furthermore, they assist in elucidating the biological roles of the SLC25A24 gene in homeostasis, paving the way for personalized medicine approaches aimed at correcting metabolic imbalances.
Compared to conventional cell lines, SLC25A24 Gene Knockout Cell Lines offer unique advantages including high specificity for the study of mitochondrial functions and metabolic pathways, ease of use in standard laboratory settings, and a robust background for follow-up studies in comparative metabolomics and proteomics. Additionally, these cell lines are rigorously validated, providing confidence in experimental reproducibility.
For researchers and clinicians focused on metabolic health, understanding mitochondrial biology, or developing innovative therapeutic approaches, SLC25A24 Gene Knockout Cell Lines represent a critical asset. Their use not only enhances the capacity to conduct impactful research but also accelerates the pathway from discovery to clinical application.
Our company has extensive experience in providing high-quality biological products and solutions tailored to cutting-edge research needs. We are dedicated to supporting scientists with reliable tools that advance the frontiers of biological sciences and enhance experimental outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.